Jinsoo Lee

Managing Director at Shinhan Venture Investment

Speaker

Jinsoo Lee has over 15 years investment experience in the global tech and healthcare sectors.

Currently he manages the Global Flagship fund ($200m) and SHGB Japan Korea fund ($30m), focusing on Korea, Japan, Southeast Asia and India.
He has invested in tech, healthcare, and contents startups across Korea and Asia, supporting them in expanding globally.

Experience:

SK Holding

-Bio, Digital Investment Center

-SK SUPEX Council Chairman’s office.

Portfolios: GenEdit(CRISPR Cas9, US), ROIVANT(Bio holding company, US) Hummingbird Bio(AI antibody drug discovery, SG), Standigm (AI drug discover, KR), Harbour BioMed (Antibody drug developer, HK)

Hanwha Asset Management/Investment Bank
- Fund of Funds (LP Investments): Khosla, DCVC, White Star Capital, Fintech Collective (US/Canada), Vertex, Golden Gate Ventures, Wavemaker (SG), Pitango (Israel) etc.

- Founding Member of ‘AI Alliance Fund’ with Hyundai Motor Company and SKT, advised by Prof. Yoshua Bengio

- Direct Investments: Yanolja (OTA), HUGEL (medical aesthetics), Carver Korea (AHC, cosmetics), DIO (digital implant), Kakao (internet), Pearl Abyss (gaming) etc.

- Led over 10 IPOs in TMT

He holds an MBA from Cornell University and double majored in Economics and Law at Sogang University.